C1 ESTERASE INHIBITOR DECREASED

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting C1 ESTERASE INHIBITOR DECREASED:

# Drug Count
0 HUMAN C1-ESTERASE INHIBITOR 6
1 EPINEPHRINE 3
2 ASPIRIN 2
3 CARVEDILOL 2
4 CITALOPRAM 2
5 DANAZOL 2
6 DIPHENHYDRAMINE HYDROCHLORIDE 2
7 ICATIBANT 2
8 LANADELUMAB-FLYO 2
9 RAMIPRIL 2
See all common drugs associated with C1 ESTERASE INHIBITOR DECREASED

C1 ESTERASE INHIBITOR DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DANAZOL 2 0.0007
1 LANADELUMAB-FLYO 2 0.0006
2 TOPOTECAN HYDROCHLORIDE 1 0.0004
3 HUMAN C1-ESTERASE INHIBITOR 6 0.0004
4 LEVALBUTEROL HYDROCHLORIDE 1 0.0003
5 LEVALBUTEROL TARTRATE 1 0.0003
6 TOPOTECAN 1 0.0002
7 DIPHENHYDRAMINE HCL 1 0.0001
8 TOBRAMYCIN SULFATE 1 0.0001
9 EXTENDED PHENYTOIN SODIUM 1 0.0001
See all drugs enriched for association with C1 ESTERASE INHIBITOR DECREASED

C1 ESTERASE INHIBITOR DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Kallikrein Inhibitor [EPC] 2 0.0008
1 Androgen [EPC] 2 0.0001
2 Catecholamine [EPC] 3 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
5 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
6 alpha-Adrenergic Blocker [EPC] 2 0.0000
7 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
8 Anti-IgE [EPC] 1 0.0000
9 Sulfonylurea [EPC] 1 0.0000
See all drug classes enriched for association with C1 ESTERASE INHIBITOR DECREASED